Company Overview
EMERGENT BIOSOLUTIONS INC.
EBSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
53M
2025 FY
Shares Outstanding
54M
2025 FY
EPS
0.98USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1367644
Exchange
NYSE
Location
US